Condition

Non-metastatic Breast Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting2

Common interventions8

Lead sponsors shown3

Clinical trials

3 shown

Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing NeuropathyNCT06400849 · 2024-04-04

RECRUITING

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerNCT05256745 · 2023-06-06

RECRUITING

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.NCT02650193 · 2015-12-01

COMPLETED

Common interventions

Chemotherapy regimen that includes ddACDRUG1 cryotherapy alone of the upper or lower limbsDEVICE1 cryotherapy and crompression of the upper or lower limbsDEVICE1 ddAC/ddTDRUG1 HSP-130DRUG1 TCDRUG1 TCHPDRUG1 TTP488DRUG1

Leading sponsors

Centre Antoine Lacassagne 1 Georgetown University 1 Pfizer 1

Trial status mix

RECRUITING2

COMPLETED1

Phase mix

PHASE22

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.